RecruitingNot ApplicableNCT06689878
Mobile Cognitive Behavioral Therapy for Stroke
Sponsor
Weill Medical College of Cornell University
Enrollment
10 participants
Start Date
Feb 25, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This study aims to assess the feasibility and acceptability of "MAYA", a mobile cognitive behavioral therapy app for anxiety and mood disorders, in adults who have had a stroke.
Eligibility
Min Age: 40 YearsMax Age: 79 Years
Inclusion Criteria9
- Age 40-79
- Presence of clinically-significant anxiety and/or depression (as determined by an eligibility evaluation)
- Stroke that occurred 1 month or more prior to study initiation
- Capacity to provide consent
- No greater than mild cognitive difficulties based on an eligibility evaluation conducted as part of the study
- If taking medication for depression and/or anxiety, must be on a stable dose for a minimum of 8 weeks prior to study initiation
- Ability to use iPhone or iPad independently
- Home internet access
- Willingness to participate in the full study duration.
Exclusion Criteria8
- Aphasia of moderate or greater severity (as determined during an eligibility evaluation)
- Non-fluency in English
- History of a bipolar or psychotic disorder
- Current alcohol or substance use disorder
- Active suicidal ideation
- Current engagement in psychotherapy is not grounds for exclusion unless the individual's psychotherapy is primarily focused on CBT
- Severe depression and/or anxiety based on the initial evaluation and clinical judgment of the study doctor, which warrants a higher level of care and/or immediate referral to psychiatric services
- Any other clinical or medical reason in the study doctor's initial screening evaluation that suggests the study is not appropriate for the participant
Interventions
BEHAVIORALMobile Cognitive Behavioral App
A mobile cognitive behavioral therapy (CBT) app called "Maya" that includes modules with educational content and teaching and practice of strategies that address depression and anxiety after stroke.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06689878
Related Trials
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT0679339767 locations
Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment
NCT067824641 location
The CONFORM Pivotal Trial
NCT0514779283 locations
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children
NCT074536151 location